Golden rules for registrars
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Manchester-based United Pharmacies has made 80 such applications since launching last November.
Only one, in Widdrington, Northumberland, has so far been accepted by a PCT. But the company has won several others on appeal.
Dr Chris Waite, a partner at the Widdrington Surgery said that, if a pharmacy goes ahead, the practice will lose half its income and the equivalent of half a GP.
A spokeswoman for Northumberland PCT said that there had been ‘no reason to reject the application'. Under current regulations it had no choice but to accept it, she said.
The practice is now challenging the plan before the NHS Litigation Authority (NHSLA).
GPs and pharmacists alike have criticised United's scattergun approach.
Widdrington Surgery acts as a dispensary for 97 per cent of its patients, and fills 6,000 prescriptions a month. Staff say that this accounts for half its income and subsidises other services.
If United's plan goes ahead, the practice will no longer be able to dispense to 80 per cent of its patients. It would be forced to give up dispensing altogether if the recent pharmacy White Paper becomes law.
The NHSLA's decision is expected by mid May.
Comment below and tell us what you think
Quick search - use * for an abbreviated search, eg nico*
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.